Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

FBG - With all due respect, oncologists are a completely different breed of physician. They keep up to date with new therapies and treatments to a degree unlike any other branch of medicine. All's Advaxis has to do is bring something to market that is better than SOC and these oncologists WILL know about it and WILL use it. While some marketing will need to be done, I'd imagine it would be more to help physicians figure out how to help their patients pay for the treatment than it would be to get them to use it because they'll already know it works better.